What is the recommended washout period after stopping oral naltrexone before starting Norco (hydrocodone/acetaminophen)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Oral Naltrexone Washout Period Before Starting Norco

Stop oral naltrexone for 2 to 3 days before starting Norco (hydrocodone/acetaminophen) to ensure adequate opioid analgesia. 1

Rationale and Pharmacologic Basis

The 2-3 day washout period is based on the pharmacokinetics of naltrexone and its active metabolite:

  • Naltrexone plasma half-life: 4 hours
  • 6-β-naltrexol (active metabolite) half-life: 13 hours 1
  • Critical consideration: The metabolite accumulates during long-term therapy, and antagonist effects persist for 2 to 3 days after stopping 1

This recommendation comes from the 2021 Society for Perioperative Assessment and Quality Improvement (SPAQI) consensus statement published in Mayo Clinic Proceedings, which specifically addresses the perioperative management of opioid antagonists 1.

Clinical Algorithm

Step 1: Verify Opioid-Free Status

  • Ensure the patient has been off all opioids for at least 7-10 days before they started naltrexone 2
  • Patients transitioning from buprenorphine or methadone may require up to 2 weeks opioid-free 2

Step 2: Discontinue Naltrexone

  • Stop oral naltrexone 72 hours (3 days) before initiating Norco for optimal opioid receptor availability
  • The 2-3 day window accounts for complete clearance of both parent drug and active metabolites

Step 3: Initiate Norco Cautiously

  • After the 72-hour washout, start Norco at standard dosing
  • Critical warning: Patients previously on naltrexone for opioid use disorder may have upregulated opioid receptors and be at increased risk of overdose with standard opioid doses 2
  • Consider starting with lower-than-typical doses and titrating carefully

Important Caveats

Extended-Release Naltrexone (Vivitrol)

If the patient is on intramuscular extended-release naltrexone instead of oral formulation, the washout period is dramatically different: 24-30 days after the last injection 1. This extended period is necessary due to the depot formulation's prolonged release characteristics.

Risk of Precipitated Withdrawal

  • Do not restart naltrexone while the patient is taking Norco, as this will precipitate severe opioid withdrawal 2
  • Naltrexone competitively blocks opioid receptors and will immediately reverse any opioid effects

Overdose Risk After Naltrexone Discontinuation

The FDA label explicitly warns that patients may be more sensitive to lower doses of opioids after naltrexone treatment ends 2. This creates a dangerous situation where:

  • The 2-3 day washout allows opioid analgesia to work
  • But the patient's tolerance may be reduced
  • Inform family members of this increased overdose risk 2

Alternative Considerations

If pain management is needed urgently and cannot wait 2-3 days:

  • Non-opioid analgesics (NSAIDs, acetaminophen) remain fully effective during naltrexone therapy
  • Regional anesthesia or nerve blocks are not affected by naltrexone
  • Attempting to "override" naltrexone blockade with high-dose opioids is dangerous and contraindicated 2

Documentation Requirements

Ensure the patient carries identification indicating naltrexone therapy, as emergency opioid administration may be ineffective or require dangerously high doses if naltrexone is still active 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.